Alnylam Pharmaceuticals (ALNY) Convertible Debt (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Convertible Debt of $361.53 million in Q3 2026, down 65.2% from $1.04 billion a year earlier and down 64.2% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Convertible Debt (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals reported Convertible Debt of $1.01 billion, down 1.6% from FY2024.
- Annual Convertible Debt has a three-year compound annual growth rate of -0.3% (FY2022 to FY2025).
- Across earlier years, Convertible Debt came in at $1.02 billion in FY2024 (+0.4%), $1.02 billion in FY2023 (+0.4%) and $1.02 billion in FY2022.
- The Q3 2026 figure is the lowest quarterly Convertible Debt in data going back to Q3 2022.
- On a year-over-year basis, Convertible Debt has declined for four consecutive quarters, with an average decline of 8.4% over the last eight quarters.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 1.6% in Q3 2025, against a decline of 65.2% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.01 billion (Q2 2026), $1.01 billion (Q1 2026) and $1.01 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 651.09 Mn |
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Dec 31, 2010 | 10.00 Mn |
| Dec 31, 2009 | 5.00 Mn |
API Access
Alnylam Pharmaceuticals Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();